Clinical and biological interactions in affective and cognitive geriatric syndromes

American Journal of Psychiatry

Volumn 160, Issue 5, 2003, Pages 811-814

  Alexopoulos, George S ^a  

^a The Cornell Institute of Geriatric Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL EXAMINATION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMORBIDITY; EDITORIAL; FOLLOW UP; GERIATRIC CARE; HUMAN; MOOD DISORDER; PRIORITY JOURNAL; PROGNOSIS; AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; BRAIN; BRAIN DISEASE; DEMENTIA; DEPRESSION; FACTITIOUS DISEASE; GERIATRIC ASSESSMENT; NOTE; PATHOLOGY;

AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; BRAIN; BRAIN DISEASES; COGNITION DISORDERS; COMORBIDITY; DEMENTIA; DEPRESSIVE DISORDER; FACTITIOUS DISORDERS; GERIATRIC ASSESSMENT; HUMANS;

EID: 0037507222     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.5.811     Document Type: Editorial

References (18)

1. Alexopoulos GS, Borson S, Cuthbert BN, Devanand DP, Mulsant BH, Olin JT, Oslin DW: Assessment of late-life depression. Biol Psychiatry 2002; 52: 164-174
2. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T: The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry 1993; 150:1693-1699
3. Alexopoulos GS, Buckwalter K, Olin J, Martinez R, Wainscott C, Krishnan KR: Comorbidity of late-life depression: an opportunity for research in mechanisms and treatment. Biol Psychiatry 2002; 52: 543-558
4. Jorm A: Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 2000; 46: 219-227
5. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K: Depression: perspectives from affective neuroscience. Annu Rev Psychol 2002; 53:545-574
6. Zubenko GS, Moosy J, Kopp U: Neurochemical correlates of major depression in primary dementia. Arch Neurol 1990; 47:209-214
7. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606
8. Alexopoulos GS: Frontostriatal and limbic dysfunction in late-life depression. Am J Geriatr Psychiatry 2002; 10:687-695
9. Beekman ATF, Geerlings SW, Deeg DJH, Smit JH, Schoevers RS, de Beurs E, Braam AW, Penninx BWJH, van Tilburg W: The natural history of late-life depression: a 6-year prospective study in the community. Arch Gen Psychiatry 2002; 59:605-611
10. Simpson S, Baldwin RC, Jackson A, Burns AS: Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroanatomical findings in late-life depression. Psychol Med 1998; 28:1015-1026
11. Alexopoulos GS, Meyers BS, Young RC, Kalayam B, Kakuma T, Gabriele M, Hull J, Sirey JA: Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000; 57:285-290
12. de Groot JC, de Leeuw FE, Oudkerk M, Van Gijn J, Hofman A, Jolles J, Breteler MMB: Cerebral white matter lesions and cognitive function: the Rotterdam Study. Ann Neurol 2000; 47:145-151
13. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin MP, Bennett B: Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995; 37:151-160
14. O'Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B: Severe deep white matter lesions and outcomes in elderly patients with major depressive disorders: a follow-up study. BMJ 1998; 317:982-984
15. Alexopoulos GS, Kiosses DN, Choi SJ, Murphy CF, Lim KO: Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am J Psychiatry 2002; 159:1929-1932
16. Alexopoulos GS, Raue P, Arean P: Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. Am J Geriatr Psychiatry 2003; 11:46-52
17. Higaki J, Murphy GM Jr, Cordel B: Inhibition of beta-amyloid formation by haloperidol: a possible mechanism for reduced frequency of Alzheimer's disease pathology in schizophrenia. J Neurochem 1997; 68:333-336
18. b- or CT(105)-induced toxicity. Biol Psychiatry 2001; 49:240-247